| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7115ef17a0cce55f36229865e31ea6a0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-78 |
| filingDate |
1995-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c2a629c6a44579ffef7392909b6cf12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8abb3e2e0e9e6ae489bf506a8259b0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eecfc7979c401089504564225e7e5a0 |
| publicationDate |
1996-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H08231405-A |
| titleOfInvention |
Combination of tobramycin and steroids for topical ophthalmic use |
| abstract |
(57) 【Abstract】 PROBLEM TO BE SOLVED: To safely suppress inflammation when administered to the eye without inhibiting the activity of antibiotics by the action of steroid components or preventing normal wound healing. Provided is a method of making a topical ophthalmic formulation composition. An anti-inflammatory and anti-inflammatory ophthalmic pharmaceutical composition for the treatment of inflammation and / or infections and / or for topical administration to the eye as a prophylactic agent after trauma or injury to the eye is prepared. For this purpose, a mixture of a therapeutically effective amount of tobramycin and a steroid selected from the group consisting of fluorometholone and fluorometholone acetate is used. |
| priorityDate |
1988-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |